Skip to main content

Is Signaling Specificity Encoded in Arrestin Conformation?

  • Chapter
  • First Online:
The Structural Basis of Arrestin Functions

Abstract

The visual/β-arrestins perform remarkably diverse roles in cells. Possessing the capacity to detect and bind hundreds of different activated GPCRs , they are integral to the control of GPCR desensitization, internalization and intracellular trafficking. At the same time, they are able to bind and localize dozens of cargo proteins, including signaling pathway intermediates that affect the tonic level of pathway activity and in some cases confer GPCR-dependent regulation. A fundamental question in biology is how proteins like arrestins can achieve the conformational flexibility necessary to interact with so many different partners while maintaining the specificity necessary for fidelity in signal transduction . Recent data, both from static structures of arrestins in their basal and ‘activated’ conformations, and dynamic resonance energy transfer measurements, have begun to provide answers. Crystallographic and mutagenesis data indicate that the conformational shifts occurring upon receptor engagement are determined by contact between the arrestin globular domains and a relatively few residues within the GPCR intracellular loops. These contacts, in turn, impose receptor-specific arrestin conformations that influence the avidity with which it binds the receptor and its ability to engage certain downstream partners. Differences in ligand structure are likewise encoded in receptor conformation and transmitted to the arrestin, providing the physical basis for ligand ‘bias’. Resonance energy transfer data also indicate that arrestins maintain their ‘active’ conformation for a period of time after letting go of the receptor, raising the possibility that arrestins, like heterotrimeric G proteins, might be activated catalytically.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Aubry L, Guetta D, Klein G (2009) The arrestin fold: variations on a theme. Curr Genomics 10:133–142

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bhattacharya M, Anborgh PH, Babwah AV, Dale LB, Dobransky T, Benovic JL, Feldman RD, Verdi JM, Rylett RJ, Ferguson SS (2002) Beta-arrestins regulate a Ral-GDS Ral effector pathway that mediates cytoskeletal reorganization. Nat Cell Biol 4:547–555

    CAS  PubMed  Google Scholar 

  • Beaulieu JM, Sotnikova TD, Marion S, Lefkowitz RJ, Gainetdinov RR, Caron MG (2005) An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior. Cell 122:261–273

    Article  CAS  PubMed  Google Scholar 

  • Breitman M, Kook S, Gimenez LE, Lizama BN, Palazzo MC, Gurevich EV, Gurevich VV (2012) Silent scaffolds: inhibition of c-Jun N-terminal kinase 3 activity in cell by dominant-negative arrestin-3 mutant. J Biol Chem 287:19653–19664

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Charest PG, Bouvier M (2003) Palmitoylation of the V2 vasopressin receptor carboxyl tail enhances beta-arrestin recruitment leading to efficient receptor endocytosis and ERK1/2 activation. J Biol Chem 278:41541–41551

    Article  CAS  PubMed  Google Scholar 

  • Charest PG, Terrillon S, Bouvier M (2005) Monitoring agonist-promoted conformational changes of beta-arrestin in living cells by intramolecular BRET. EMBO Rep 6:334–340

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Claing A, Chen W, Miller WE, Vitale N, Moss J, Premont RT, Lefkowitz RJ (2001) Beta-arrestin-mediated ADP-ribosylation factor 6 activation and beta 2-adrenergic receptor endocytosis. J Biol Chem 276:42509–42513

    Article  CAS  PubMed  Google Scholar 

  • Coffa S, Breitman M, Hanson SM, Callaway K, Kook S, Dalby KN, Gurevich VV (2011) The effect of arrestin conformation on the recruitment of c-Raf1, MEK1, and ERK1/2 activation. PLoS One 6:e28723

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • DeFea KA, Vaughn ZD, O’Bryan EM, Nishijima D, Dery O, Bunnett NW (2000a) The proliferative and antiapoptotic effects of substance P are facilitated by formation of a beta-arrestin-dependent scaffolding complex. Proc Natl Acad Sci U S A 97:11086–11091

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • DeFea KA, Zalevsky J, Thoma MS, Dery O, Mullins RD, Bunnett NW (2000b) Beta-arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2. J Cell Biol 148:1267–1281

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ferguson SS (2001) Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol Rev 53:1–24

    CAS  PubMed  Google Scholar 

  • Furness SG, Liang YL, Nowell CJ, Halls ML, Wookey PJ, Dal Maso E, Inoue A, Christopoulos A, Wootten D, Sexton PM (2016) Ligand-dependent modulation of G protein conformation alters drug efficacy. Cell 167:739–749

    Article  CAS  PubMed  Google Scholar 

  • Galandrin S, Oligny-Longpré G, Bouvier M (2007) The evasive nature of drug efficacy: implications for drug discovery. Trends Pharmacol Sci 28:423–430

    Article  CAS  PubMed  Google Scholar 

  • Gesty-Palmer D, Yuan L, Martin B, Wood WH 3rd, Lee MH, Janech MG, Tsoi LC, Zheng WJ, Luttrell LM, Maudsley S (2013) β-arrestin-selective G protein-coupled receptor agonists engender unique biological efficacy in vivo. Mol Endocrinol 27:296–314

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gimenez LE, Kook S, Vishnivetskiy SA, Ahmed MR, Gurevich EV, Gurevich VV (2012a) Role of receptor-attached phosphates in binding of visual and non-visual arrestins to G protein-coupled receptors. J Biol Chem 287:9028–9040

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gimenez LE, Vishnivetskiy SA, Baameur F, Gurevich VV (2012b) Manipulation of very few receptor discriminator residues greatly enhances receptor specificity of non-visual arrestins. J Biol Chem 287:29495–29505

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gimenez LE, Babilon S, Wanka L, Beck-Sickinger AG, Gurevich VV (2014) Mutations in arrestin-3 differentially affect binding to neuropeptide Y receptor subtypes. Cell Signal 26:1523–1531

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Goodman OB Jr, Krupnick JG, Santini F, Gurevich VV, Penn RB, Gagnon AW, Keen JH, Benovic JL (1996) Beta-arrestin acts as a clathrin adaptor in endocytosis of the beta2-adrenergic receptor. Nature 383:447–450

    Article  CAS  PubMed  Google Scholar 

  • Granzin J, Cousin A, Weirauch M, Schlesinger R, Buldt G, Batra-Safferling R (2012) Crystal structure of p44, a constitutively active splice variant of visual arrestin. J Mol Biol 416:611–618

    Article  CAS  PubMed  Google Scholar 

  • Granzin J, Wilden U, Choe HW, Labahn J, Krafft B, Büldt G (1998) X-ray crystal structure of arrestin from bovine rod outer segments. Nature 391:918–921

    Article  CAS  PubMed  Google Scholar 

  • Gurevich VV, Benovic JL (1993) Visual arrestin interaction with rhodopsin. Sequential multisite binding ensures strict selectivity toward light-activated phosphorylated rhodopsin. J Biol Chem 268:11628–11638

    CAS  PubMed  Google Scholar 

  • Gurevich VV, Benovic JL (1995) Visual arrestin binding to rhodopsin. Diverse functional roles of positively charged residues within the phosphorylation-recognition region of arrestin. J Biol Chem 270:6010–6016

    Article  CAS  PubMed  Google Scholar 

  • Gurevich VV, Benovic JL (1997) Mechanism of phosphorylation-recognition by visual arrestin and the transition of arrestin into a high affinity binding state. Mol Pharmacol 51:161–169

    CAS  PubMed  Google Scholar 

  • Gurevich VV, Gurevich EV (2013) Structural determinants of arrestin functions. Prog Mol Biol Transl Sci 118:57–92

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Han M, Gurevich VV, Vishnivetskiy SA, Sigler PB, Schubert C (2001) Crystal structure of beta-arrestin at 1.9 A: possible mechanism of receptor binding and membrane Translocation. Structure 9:869–880

    Article  CAS  PubMed  Google Scholar 

  • Hanson SM, Francis DJ, Vishnivetskiy SA, Kolobova EA, Hubbell WL, Klug CS, Gurevich VV (2006) Differential interaction of spin-labeled arrestin with inactive and active phosphorhodopsin. Proc Natl Acad Sci U S A 103:4900–4905

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hanson SM, Cleghorn WM, Francis DJ, Vishnivetskiy SA, Raman D, Song X, Nair KS, Slepak VZ, Klug CS, Gurevich VV (2007) Arrestin mobilizes signaling proteins to the cytoskeleton and redirects their activity. J Mol Biol 368:375–387

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kang Y, Zhou XE, Gao X, He Y, Liu W, Ishchenko A, Barty A, White TA, Yefanov O, Han GW, Xu Q, de Waal PW, Ke J, Tan MH, Zhang C, Moeller A, West GM, Pascal BD, Van Eps N, Caro LN, Vishnivetskiy SA, Lee RJ, Suino-Powell KM, Gu X, Pal K, Ma J, Zhi X, Boutet S, Williams GJ, Messerschmidt M, Gati C, Zatsepin NA, Wang D, James D, Basu S, Roy-Chowdhury S, Conrad CE, Coe J, Liu H, Lisova S, Kupitz C, Grotjohann I, Fromme R, Jiang Y, Tan M, Yang H, Li J, Wang M, Zheng Z, Li D, Howe N, Zhao Y, Standfuss J, Diederichs K, Dong Y, Potter CS, Carragher B, Caffrey M, Jiang H, Chapman HN, Spence JC, Fromme P, Weierstall U, Ernst OP, Katritch V, Gurevich VV, Griffin PR, Hubbell WL, Stevens RC, Cherezov V, Melcher K, Xu HE (2015) Crystal structure of rhodopsin bound to arrestin by femtosecond X-ray laser. Nature 523:561–567

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kenakin TP (2009) 7TM receptor allostery: putting numbers to shapeshifting proteins. Trends Pharmacol Sci 30:460–469

    Article  CAS  PubMed  Google Scholar 

  • Kenakin TP (2012) Biased signalling and allosteric machines: new vistas and challenges for drug discovery. Br J Pharmacol 165:1659–1669

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kenakin T, Miller LJ (2010) Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery. Pharmacol Rev 62:265–304

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Khoury E, Nikolajev L, Simaan M, Namkung Y, Laporte SA (2014) Differential regulation of endosomal GPCR/β-arrestin complexes and trafficking by MAPK. J Biol Chem 289:23302–23317

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kim J, Ahn S, Ren XR, Whalen EJ, Reiter E, Wei H, Lefkowitz RJ (2005) Functional antagonism of different G protein-coupled receptor kinases for beta-arrestin-mediated angiotensin II receptor signaling. Proc Natl Acad Sci U S A 102:1442–1447

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kim YJ, Hofmann KP, Ernst OP, Scheerer P, Choe HW, Sommer ME (2013) Crystal structure of pre-activated arrestin p44. Nature 497:142–146

    Article  CAS  PubMed  Google Scholar 

  • Kirchberg K, Kim TY, Möller M, Skegro D, Dasara Raju G, Granzin J, Büldt G, Schlesinger R, Alexiev U (2011) Conformational dynamics of helix 8 in the GPCR rhodopsin controls arrestin activation in the desensitization process. Proc Natl Acad Sci U S A 108:18690–18695

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kisselev OG, Downs MA, McDowell JH, Hargrave PA (2004) Conformational changes in the phosphorylated C-terminal domain of rhodopsin during rhodopsin arrestin interactions. J Biol Chem 279:51203–51207

    Article  CAS  PubMed  Google Scholar 

  • Kovoor A, Celver J, Abdryashitov RI, Chavkin C, Gurevich VV (1999) Targeted construction of phosphorylation-independent beta-arrestin mutants with constitutive activity in cells. J Biol Chem 274:6831–6834

    Article  CAS  PubMed  Google Scholar 

  • Krasel C, Bünemann M, Lorenz K, Lohse MJ (2005) β-Arrestin binding to the β2-adrenergic receptor requires both receptor phosphorylation and receptor activation. J Biol Chem 280:9528–9535

    Article  CAS  PubMed  Google Scholar 

  • Laporte SA, Oakley RH, Zhang J, Holt JA, Ferguson SS, Caron MG, Barak LS (1999) The beta2-adrenergic receptor/betaarrestin complex recruits the clathrin adaptor AP-2 during endocytosis. Proc Natl Acad Sci U S A 96:3712–3717

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lee M-H, Appleton KM, Strungs EG, Kwon JY, Morinelli TA, Peterson YK, Laporte SA, Luttrell LM (2016) The conformational signature of activated arrestin3 predicts its trafficking and signaling functions. Nature 531:665–668

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Liggett SB (2011) Phosphorylation barcoding as a mechanism of directing GPCR signaling. Sci Signal 4:pe36

    Article  CAS  PubMed  Google Scholar 

  • Lin A, DeFea KA (2013) β-Arrestin-kinase scaffolds: turn them on or turn them off? Wiley Interdiscip Rev Syst Biol Med 5:231–241

    Article  CAS  PubMed  Google Scholar 

  • Lin FT, Krueger KM, Kendall HE, Daaka Y, Fredericks ZL, Pitcher JA, Lefkowitz RJ (1997) Clathrin-mediated endocytosis of the beta-adrenergic receptor is regulated by phosphorylation/dephosphorylation of beta-arrestin1. J Biol Chem 272:31051–31057

    Article  CAS  PubMed  Google Scholar 

  • Luttrell LM, Ferguson SS, Daaka Y, Miller WE, Maudsley S, Della Rocca GJ, Lin F, Kawakatsu H, Owada K, Luttrell DK, Caron MG, Lefkowitz RJ (1999) Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes. Science 283:655–661

    Article  CAS  PubMed  Google Scholar 

  • Luttrell LM, Gesty-Palmer D (2010) Beyond desensitization: physiological relevance of arrestin-dependent signaling. Pharmacol Rev 62:305–330

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Luttrell LM, Kenakin TP (2011) Refining efficacy: allosterism and bias in G protein-coupled receptor signaling. Methods Mol Biol 756:3–35

    Article  CAS  PubMed  Google Scholar 

  • Luttrell LM, Roudabush FL, Choy EW, Miller WE, Field ME, Pierce KL, Lefkowitz RJ (2001) Activation and targeting of extracellular signal-regulated kinases by beta-arrestin scaffolds. Proc Natl Acad Sci U S A 98:2449–2454

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Manglik A, Kobilka B (2014) The role of protein dynamics in GPCR function: insights from the β2AR and rhodopsin. Curr Opin Cell Biol 27:136–1143

    Article  CAS  PubMed  Google Scholar 

  • Maudsley S, Martin B, Gesty-Palmer D, Cheung H, Johnson C, Patel S, Becker KG, Wood WH 3rd, Zhang Y, Lehrmann E, Luttrell LM (2015) Delineation of a conserved arrestin-biased signaling repertoire in vivo. Mol Pharmacol 87:706–717

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • McDonald PH, Chow CW, Miller WE, Laporte SA, Field ME, Lin FT, Davis RJ, Lefkowitz RJ (2000) Beta-arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3. Science 290(5496):1574–1577

    Google Scholar 

  • Milano SK, Kim YM, Stefano FP, Benovic JL, Brenner C (2006) Nonvisual arrestin oligomerization and cellular localization are regulated by inositol hexakisphosphate binding. J Biol Chem 281:9812–9823

    Article  CAS  PubMed  Google Scholar 

  • Nair KS, Hanson SM, Kennedy MJ, Hurley JB, Gurevich VV, Slepak VZ (2004) Direct binding of visual arrestin to microtubules determines the differential subcellular localization of its splice variants in rod photoreceptors. J Biol Chem 279:41240–41248

    Article  CAS  PubMed  Google Scholar 

  • Nelson CD, Perry SJ, Regier DS, Prescott SM, Topham MK, Lefkowitz RJ (2007) Targeting of diacylglycerol degradation to M1 muscarinic receptors by beta-arrestins. Science 315:663–666

    Article  CAS  PubMed  Google Scholar 

  • Nobles KN, Xiao K, Ahn S, Shukla AK, Lam CM, Rajagopal S, Strachan RT, Huang TY, Bressler EA, Hara MR, Shenoy SK, Gygi SP, Lefkowitz RJ (2011) Distinct phosphorylation sites on the beta2-adrenergic receptor establish a barcode that encodes differential functions of beta-arrestin. Sci Signal 4:ra51

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Nuber S, Zabel U, Lorenz K, Nuber A, Milligan G, Tobin AB, Lohse MJ, Hoffmann C (2016) FRET-based β-arrestin biosensors reveal a rapid, receptor-dependent activation/deactivation cycle in living cells. Nature 531:661–664

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Oakley RH, Laporte SA, Holt JA, Caron MG, Barak LS (2000) Differential affinities of visual arrestin, beta arrestin1, and beta arrestin2 for G protein-coupled receptors delineate two major classes of receptors. J Biol Chem 275:17201–17210

    Article  CAS  PubMed  Google Scholar 

  • Oakley RH, Laporte SA, Holt JA, Barak LS, Caron MG (2001) Molecular determinants underlying the formation of stable intracellular G protein-coupled receptor-beta-arrestin complexes after receptor endocytosis. J Biol Chem 276:19452–19460

    Article  CAS  PubMed  Google Scholar 

  • Perry SJ, Baillie GS, Kohout TA, McPhee I, Magiera MM, Ang KL, Miller WE, McLean AJ, Conti M, Houslay MD, Lefkowitz RJ (2002) Targeting of cyclic AMP degradation to beta 2-adrenergic receptors by beta-arrestins. Science 298:834–836

    Article  CAS  PubMed  Google Scholar 

  • Ren XR, Reiter E, Ahn S, Kim J, Chen W, Lefkowitz RJ (2005) Different G protein-coupled receptor kinases govern G protein and beta-arrestin-mediated signaling of V2 vasopressin receptor. Proc Natl Acad Sci U S A 102:1448–1453

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Schröder K, Pulvermüller A, Hofmann KP (2002) Arrestin and its splice variant Arr1-370A (p44). Mechanism and biological role of their interaction with rhodopsin. J Biol Chem 277:43987–43996

    Article  PubMed  Google Scholar 

  • Shenoy SK, Lefkowitz RJ (2005a) Angiotensin II-stimulated signaling through G proteins and beta-arrestin. Sci STKE 2005(308):cm10

    PubMed  Google Scholar 

  • Shenoy SK, Lefkowitz RJ (2005b) Receptor-specific ubiquitination of beta-arrestin directs assembly and targeting of seven-transmembrane receptor signalosomes. J Biol Chem 280:15315–15324

    Article  CAS  PubMed  Google Scholar 

  • Shenoy SK, Barak LS, Xiao K, Ahn S, Berthouze M, Shukla AK, Luttrell LM, Lefkowitz RJ (2007) Ubiquitination of beta-arrestin links seven-transmembrane receptor endocytosis and ERK activation. J Biol Chem 282:29549–29562

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Shenoy SK, McDonald PH, Kohout TA, Lefkowitz RJ (2001) Regulation of receptor fate by ubiquitination of activated β2-adrenergic receptor and β-arrestin. Science 294:1307–1313

    Article  CAS  PubMed  Google Scholar 

  • Shenoy SK, Modi AS, Shukla AK, Xiao K, Berthouze M, Ahn S, Wilkinson KD, Miller WE, Lefkowitz RJ (2009) Beta-arrestin-dependent signaling and trafficking of 7-transmembrane receptors is reciprocally regulated by the deubiquitinase USP33 and the E3 ligase Mdm2. Proc Natl Acad Sci U S A 106:6650–6655

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Shenoy SK, Xiao K, Venkataramanan V, Snyder PM, Freedman NJ, Weissman AM (2008) Nedd4 mediates agonist-dependent ubiquitination, lysosomal targeting, and degradation of the beta2-adrenergic receptor. J Biol Chem 283:22166–22176

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Shukla AK, Manglik A, Kruse AC, Xiao K, Reis RI, Tseng WC, Staus DP, Hilger D, Uysal S, Huang LY, Paduch M, Tripathi-Shukla P, Koide A, Koide S, Weis WI, Kossiakoff AA, Kobilka BK, Lefkowitz RJ (2013) Structure of active beta-arrestin-1 bound to a G-protein-coupled receptor phosphopeptide. Nature 497:137–141

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Shukla AK, Westfield GH, Xiao K, Reis RI, Huang LY, Tripathi-Shukla P, Qian J, Li S, Blanc A, Oleskie AN, Dosey AM, Su M, Liang CR, Gu LL, Shan JM, Chen X, Hanna R, Choi M, Yao XJ, Klink BU, Kahsai AW, Sidhu SS, Koide S, Penczek PA, Kossiakoff AA, Woods VL Jr, Kobilka BK, Skiniotis G, Lefkowitz RJ (2014) Visualization of arrestin recruitment by a G-protein-coupled receptor. Nature 512:218–222

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Shukla AK, Violin JD, Whalen EJ, Gesty-Palmer D, Shenoy SK, Lefkowitz RJ (2008) Distinct conformational changes in beta-arrestin report biased agonism at seven-transmembrane receptors. Proc Natl Acad Sci U S A 105:9988–9993

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sommer ME, Farrens DL, McDowell JH, Weber LA, Smith WC (2007) Dynamics of arrestin–rhodopsin interactions: loop movement is involved in arrestin activation and receptor binding. J Biol Chem 282:25560–25568

    Article  CAS  PubMed  Google Scholar 

  • Song X, Raman D, Gurevich EV, Vishnivetskiy SA, Gurevich VV (2006) Visual and both non-visual arrestins in their “inactive” conformation bind JNK3 and Mdm2 and relocalize them from the nucleus to the cytoplasm. J Biol Chem 281:21491–21499

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Szczepek M, Beyriere F, Hofmann KP, Elgeti M, Kazmin R, Rose A, Bartl FJ, von Stetten D, Heck M, Sommer ME, Hildebrand PW, Scheerer P (2014) Crystal structure of a common GPCR-binding interface for G protein and arrestin. Nat Commun 5:4801

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tobin AB, Butcher AJ, Kong KC (2008) Location, location, location…site-specific GPCR phosphorylation offers a mechanism for cell-type-specific signalling. Trends Pharmacol Sci 29:413–420

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Vishnivetskiy SA, Schubert C, Climaco GC, Gurevich YV, Velez MG, Gurevich VV (2000) An additional phosphate-binding element in arrestin molecule. Implications for the mechanism of arrestin activation. J Biol Chem 275:41049–41057

    Article  CAS  PubMed  Google Scholar 

  • Vishnivetskiy SA, Hirsch JA, Velez MG, Gurevich YV, Gurevich VV (2002) Transition of arrestin into the active receptor-binding state requires an extended interdomain hinge. J Biol Chem 277:43961–43967

    Article  CAS  PubMed  Google Scholar 

  • Vishnivetskiy SA, Gimenez LE, Francis DJ, Hanson SM, Hubbell WL, Klug CS, Gurevich VV (2011) Few residues within an extensive binding interface drive receptor interaction and determine the specificity of arrestin proteins. J Biol Chem 286:24288–24299

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Witherow DS, Garrison TR, Miller WE, Lefkowitz RJ (2004) beta-Arrestin inhibits NF-kappaB activity by means of its interaction with the NF-kappaB inhibitor IkappaBalpha. Proc Natl Acad Sci U S A 101:8603–8607

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wu N, Hanson SM, Francis DJ, Vishnivetskiy SA, Thibonnier M, Klug CS, Shoham M, Gurevich VV (2006) Arrestin binding to calmodulin: a direct interaction between two ubiquitous signaling proteins. J Mol Biol 364:955–963

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Xiao K, McClatchy DB, Shukla AK, Zhao Y, Chen M, Shenoy SK, Yates JR 3rd, Lefkowitz RJ (2007) Functional specialization of beta-arrestin interactions revealed by proteomic analysis. Proc Natl Acad Sci U S A 104:12011–12016

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zhan X, Gimenez LE, Gurevich VV, Spiller BW (2011) Crystal structure of arrestin-3 reveals the basis of the difference in receptor binding between two non-visual subtypes. J Mol Biol 406:467–478

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zhuang T, Vishnivetskiy SA, Gurevich VV, Sanders CR (2010) Elucidation of inositol hexaphosphate and heparin interaction sites and conformational changes in arrestin-1 by solution nuclear magnetic resonance. Biochemistry 49:10473–10485

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zhuo Y, Vishnivetskiy SA, Zhan X, Gurevich VV, Klug CS (2014) Identification of receptor binding-induced conformational changes in non-visual arrestins. J Biol Chem 289:20991–21002

    Google Scholar 

  • Zimmerman B, Beautrait A, Aguila B, Charles R, Escher E, Claing A, Bouvier M, Laporte SA (2012) Differential β-arrestin-dependent conformational signaling and cellular responses revealed by angiotensin analogs. Sci Signal 5:ra33

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

Supported by National Institutes of Health Grants R01 DK055524 (LML), R01 GM095497 (LML), Department of Veterans Affairs Merit Review Grant I01 BX003188 (LML), and the Research Service of the Charleston, SC Veterans Affairs Medical Center. The contents of this article do not represent the views of the Department of Veterans Affairs or the United States Government.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Louis M. Luttrell .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Hoffmann, C., Lohse, M.J., Luttrell, L.M. (2017). Is Signaling Specificity Encoded in Arrestin Conformation?. In: Gurevich, V. (eds) The Structural Basis of Arrestin Functions. Springer, Cham. https://doi.org/10.1007/978-3-319-57553-7_17

Download citation

Publish with us

Policies and ethics